CA
ABBV icon

CapWealth Advisors’s AbbVie ABBV Stock Holding History

CapWealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+799
New +$172K 0.01% 113
2024
Q4 		– Sell
-1,262
Closed -$249K – 102
2024
Q3 		$249K Buy
1,262
+92
+8% +$17.2K 0.03% 99
2024
Q2 		$201K Buy
1,170
+1
+0.1% +$166 0.03% 97
2024
Q1 		$213K Sell
1,169
-1,658
-59% -$286K 0.02% 94
2023
Q4 		$438K Buy
2,827
+284
+11% +$41.4K 0.05% 70
2023
Q3 		$379K Sell
2,543
-340
-12% -$49.9K 0.05% 77
2023
Q2 		$388K Sell
2,883
-60
-2% -$8.8K 0.05% 78
2023
Q1 		$469K Sell
2,943
-99
-3% -$15.1K 0.06% 75
2022
Q4 		$492K Buy
3,042
+400
+15% +$61.3K 0.06% 80
2022
Q3 		$355K Sell
2,642
-308
-10% -$44.2K 0.05% 85
2022
Q2 		$452K Buy
2,950
+283
+11% +$43.2K 0.05% 84
2022
Q1 		$432K Hold
2,667
– – 0.04% 94
2021
Q4 		$361K Buy
+2,667
New +$315K 0.04% 98
2016
Q4 		– Sell
-1,545
Closed -$97K – 93
2016
Q3 		$97K Sell
1,545
-13
-0.8% -$842 0.02% 110
2016
Q2 		$96K Sell
1,558
-239
-13% -$14.6K 0.02% 111
2016
Q1 		$103K Buy
1,797
+639
+55% +$35.6K 0.03% 104
2015
Q4 		$69K Sell
1,158
-28
-2% -$1.61K 0.02% 114
2015
Q3 		$65K Sell
1,186
-100
-8% -$6.51K 0.02% 112
2015
Q2 		$86K Buy
1,286
+220
+21% +$14.4K 0.02% 108
2015
Q1 		$62K Buy
+1,066
New +$64.4K 0.01% 123
2014
Q4 		– Sell
-1,066
Closed -$62K – 89
2014
Q3 		$62K Hold
1,066
– – 0.01% 122
2014
Q2 		$60K Sell
1,066
-1,000
-48% -$52.5K 0.01% 130
2014
Q1 		$106K Hold
2,066
– – 0.03% 102
2013
Q4 		$109K Hold
2,066
– – 0.03% 108
2013
Q3 		$92K Hold
2,066
– – 0.03% 118
2013
Q2 		$85K Buy
+2,066
New +$90.4K 0.02% 122

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CapWealth Advisors's ABBV Position: Q2 2026 in Review

CapWealth Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 799 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #113 among its holdings. This is a return to the name: CapWealth Advisors previously reported a position in ABBV as recently as Q3 2024.

CapWealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 26 quarters since. The position peaked at $492K in Q4 2022. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CapWealth Advisors held 799 shares of AbbVie worth $201K as of Q2 2026.
  • AbbVie was a new CapWealth Advisors position in Q2 2026.
  • AbbVie made up 0.01% of CapWealth Advisors's portfolio in Q2 2026, its #113 holding.
  • CapWealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 26 quarters since.
  • CapWealth Advisors's AbbVie position peaked at $492K in Q4 2022.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CapWealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.